Veritas, Luthra, Herbert, Latham lead on Claris sale of generic injectables biz to Baxter for $625 million

Bar & Bench December 16 2016

Claris Lifesciences Ltd will sell its global generic injectables business to US-based Baxter International Inc. for $625 million (Rs. 4,238 crore).

Veritas Legal and AZB & Partners acted as domestic legal counsel for Claris Lifesciences while Herbert Smith acted as international counsel.

The Veritas team was led by Partners Abhijit Joshi and Tusha Raut.

The AZB team was led by Partner Anand Shah

You need to have an active subscription to view this content.